Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 1 38Phase 1/2 21Phase EARLY_PHASE1 2Phase 3 2Phase 4 1

Status

Completed 4Active not recruiting 3Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Uveal Melanoma 1Melanoma 1

Interventions

Magnetic Resonance Spectroscopy 7Cyclophosphamide 6pembrolizumab 5Radiosurgery 5Nivolumab 4Fluorouracil 4Carboplatin 4Blood Specimen Collection 4Biopsy 4X-Rays 3Vincristine 3Surveys and Questionnaires 3Proflavine 3Positron-Emission Tomography 3Metformin 3Cisplatin 3Bevacizumab 3fludarabine phosphate 2durvalumab 2atezolizumab 2Varenicline 2Topotecan 2Taxes 2Specimen Handling 2Rituximab 2Radiotherapy 2Positron Emission Tomography Computed Tomography 2Oxaliplatin 2Leucovorin 2Letrozole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Ipilimumab × Clear all
NCT03526185 2022-07-25

A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes

Yale University

Phase EARLY_PHASE1 Terminated
6 enrolled
Dermatologic

Melanoma

NCT01730157 2016-03-10

Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
6 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡